#Lauruslabs results - opportunity in disguise
Putting slides from my BQ talk. Execution, Innovation and Ability to scale – No other company in chemicals and pharma match Laurus on these 3
video of Laurus Bio – listen from 6 min…
Putting slides from my BQ talk. Execution, Innovation and Ability to scale – No other company in chemicals and pharma match Laurus on these 3
video of Laurus Bio – listen from 6 min…
you will understand what potential Laurus Bio holds..this will be largest in the world in AOF recombinant proteins
KTA
-CDMO will be 25% of total sales by FY25..(My estimate is 10000 crs total sales in FY25, so 2500 crs from CDMO. If it gets 20x P/S,
KTA
-CDMO will be 25% of total sales by FY25..(My estimate is 10000 crs total sales in FY25, so 2500 crs from CDMO. If it gets 20x P/S,
30% PAT margins and 70x PE, that itself will be valued at 50,000 crs against total MCap of 25,000 today)
-Fermentation capacity target is 3 Mn lit in the future. Current capacity can have run rate of 40 crs per qtr
-Confident of $1 Bn sales in FY23 if approvals come on time
-Fermentation capacity target is 3 Mn lit in the future. Current capacity can have run rate of 40 crs per qtr
-Confident of $1 Bn sales in FY23 if approvals come on time
• • •
Missing some Tweet in this thread? You can try to
force a refresh
